Explore the complete record of transactions filed by Bailey Gregory. Officer active across 3 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Cumulatively, 26 disclosures have been logged. Split: 21 buys · 0 sell. Total volume traded: €14.5m. History available since 19 August 2022. The latest transaction was filed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bailey Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Bailey Gregory is a declarant and Director of Serina Therapeutics, Inc., Biohaven Ltd., and Biohaven Pharmaceutical Holding Co Ltd. He has 26 filings in total, and across the 26 sampled filings, purchases amount to EUR 14,467,672 and sales to EUR 390,226,335, with activity ranging from 2022-08-22 to 2026-06-22. The modal transaction nature is Acquisition.